PAPER Önmez A, Alpay M, Torun S, Şahin İE, Öneç K, Değirmenci Y
SEARCH RESULTS
3546 RESULTS
PAPER Liu Y, Bai H, Gen S, Zhang H, Wang S, Hua L, Yang X, Zhang S, Li J, Wang Y
Interaction between SNCA gene polymorphisms and T2DM with Parkinson's disease.
Acta Neurol Scand. 2020 Nov;142(5):443-448. Epub 2020 Jul 3 PubMed: 32484913PAPER Gasca-Salas C, Duff-Canning S, Armstrong MJ, Eslinger PJ, Schneider RB, Kennedy N, Chou KL, Persad C, Litvan I, Weintraub S, Marras C
Parkinson disease with mild cognitive impairment: Domain-specific cognitive complaints predict dementia.
Acta Neurol Scand. 2020 Dec;142(6):585-596. Epub 2020 Aug 16 PubMed: 32740919PAPER Abbott NJ, Pizzo ME, Preston JE, Janigro D, Thorne RG
The role of brain barriers in fluid movement in the CNS: is there a 'glymphatic' system?
Acta Neuropathol. 2018 Mar;135(3):387-407. Epub 2018 Feb 10 PubMed: 29428972PAPER Holec SA, Woerman AL
Evidence of distinct α-synuclein strains underlying disease heterogeneity.
Acta Neuropathol. 2020 May 21; PubMed: 32440702PAPER Fanning S, Selkoe D, Dettmer U
Vesicle trafficking and lipid metabolism in synucleinopathy.
Acta Neuropathol. 2020 Jun 30; PubMed: 32607605PAPER LaClair KD, Zhou Q, Michaelsen M, Wefers B, Brill MS, Janjic A, Rathkolb B, Farny D, Cygan M, de Angelis MH, Wurst W, Neumann M, Enard W, Misgeld T, Arzberger T, Edbauer D
Congenic expression of poly-GA but not poly-PR in mice triggers selective neuron loss and interferon responses found in C9orf72 ALS.
Acta Neuropathol. 2020 Aug;140(2):121-142. Epub 2020 Jun 19 PubMed: 32562018PAPER Lau HH, Ingelsson M, Watts JC
The existence of Aβ strains and their potential for driving phenotypic heterogeneity in Alzheimer's disease.
Acta Neuropathol. 2020 Aug 2; PubMed: 32743745PAPER Ittner A, Asih PR, Tan AR, Prikas E, Bertz J, Stefanoska K, Lin Y, Volkerling AM, Ke YD, Delerue F, Ittner LM
Reduction of advanced tau-mediated memory deficits by the MAP kinase p38γ.
Acta Neuropathol. 2020 Sep;140(3):279-294. Epub 2020 Jul 29 PubMed: 32725265PAPER Lantero Rodriguez J, Karikari TK, Suárez-Calvet M, Troakes C, King A, Emersic A, Aarsland D, Hye A, Zetterberg H, Blennow K, Ashton NJ
Plasma p-tau181 accurately predicts Alzheimer's disease pathology at least 8 years prior to post-mortem and improves the clinical characterisation of cognitive decline.
Acta Neuropathol. 2020 Sep;140(3):267-278. Epub 2020 Jul 27 PubMed: 32720099PAPER Readhead B, Haure-Mirande JV, Mastroeni D, Audrain M, Fanutza T, Kim SH, Blitzer RD, Gandy S, Dudley JT, Ehrlich ME
miR155 regulation of behavior, neuropathology, and cortical transcriptomics in Alzheimer's disease.
Acta Neuropathol. 2020 Sep;140(3):295-315. Epub 2020 Jul 14 PubMed: 32666270PAPER Younas N, Zafar S, Shafiq M, Noor A, Siegert A, Arora AS, Galkin A, Zafar A, Schmitz M, Stadelmann C, Andreoletti O, Ferrer I, Zerr I
SFPQ and Tau: critical factors contributing to rapid progression of Alzheimer's disease.
Acta Neuropathol. 2020 Sep;140(3):317-339. Epub 2020 Jun 23 PubMed: 32577828PAPER Dai DL, Tropea TF, Robinson JL, Suh E, Hurtig H, Weintraub D, Van Deerlin V, Lee EB, Trojanowski JQ, Chen-Plotkin AS
ADNC-RS, a clinical-genetic risk score, predicts Alzheimer's pathology in autopsy-confirmed Parkinson's disease and Dementia with Lewy bodies.
Acta Neuropathol. 2020 Oct;140(4):449-461. Epub 2020 Aug 4 PubMed: 32749525PAPER Kent SA, Spires-Jones TL, Durrant CS
The physiological roles of tau and Aβ: implications for Alzheimer's disease pathology and therapeutics.
Acta Neuropathol. 2020 Oct;140(4):417-447. Epub 2020 Jul 29 PubMed: 32728795PAPER Kovacs GG, Robinson JL, Perl DP, Lee VM, Trojanowski JQ